Skip to main content

Amlodipine / hydrochlorothiazide / valsartan Side Effects

Medically reviewed by Drugs.com. Last updated on Jan 22, 2024.

Applies to amlodipine / hydrochlorothiazide / valsartan: oral tablet.

Warning

Oral route (Tablet)

Drugs with direct action on the renin-angiotensin system can cause injury or death to the developing fetus. Stop therapy as soon as possible when pregnancy occurs.

Serious side effects

Along with its needed effects, amlodipine/hydrochlorothiazide/valsartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking amlodipine/hydrochlorothiazide/valsartan:

More common

Rare

Other side effects

Some side effects of amlodipine / hydrochlorothiazide / valsartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

Rare

For Healthcare Professionals

Applies to amlodipine / hydrochlorothiazide / valsartan: oral tablet.

Cardiovascular

Rare (less than 0.1%): Palpitations, chest pain, angioedema

Uncommon (0.1% to 1%): Orthostatic hypotension, postural dizziness

Frequency not reported: Cardiac arrhythmias (including ventricular ectopy and complete AV heart block)

-Amlodipine component: Arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, peripheral ischemia, syncope, postural hypotension, vasculitis

-Hydrochlorothiazide component: Cardiac arrhythmias (including ventricular ectopy and complete AV heart block associated with hypokalemia and hyponatremia)

-Valsartan component: Dizziness related to orthostatic hypotension, palpitations, chest pain[Ref]

Dermatologic

Frequency not reported: Erythema annular centrifugum, acute eczematous dermatitis, morbilliform, leukocytoclastic vasculitis, phototoxic dermatitis, subacute cutaneous lupus erythematosus-like condition, pruritus, rash, hyperhidrosis

-Amlodipine component: Angioedema, erythema multiforme, rash erythematosus, rash maculopapular

-Hydrochlorothiazide component: Erythema annular centrifugum, acute eczematous dermatitis, morbilliform, leukocytoclastic vasculitis, phototoxic dermatitis, a rare subacute lupus erythematosus-like reaction[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Diarrhea, constipation, appetite changes, dry mouth, dyspepsia, nausea, vomiting, flatulence, pancreatitis, cholecystitis, abdominal pain, toothache, gastritis, anorexia, dehydration, hemorrhoids

-Amlodipine component: Frequency not reported Anorexia, dysphagia, pancreatitis, gingival hyperplasia

-Hydrochlorothiazide component: Rare (less than 0.1%): Pancreatitis, nausea, acute cholecystitis

-Valsartan component: Rare (less than 0.1%): Diarrhea, constipation, dry mouth, dyspepsia, anorexia, nausea, vomiting, taste disturbance, flatulence[Ref]

Hematologic

Common (1% to 10%): Neutropenia

Uncommon (0.1% to 1%): Hematocrit decreased, hemoglobin decreased

Rare (0.01% to 0.1%): Immune complex hemolytic anemia

Postmarketing reports: Thrombocytopenia

-Amlodipine component: Frequency not reported: Leucopenia, purpura, thrombocytopenia

-Hydrochlorothiazide component Frequency not reported: Aplastic anemia, agranulocytosis, hemolytic anemia

-Valsartan component: Frequency not reported: Decreases in hematocrit or hemoglobin, neutropenia, thrombocytopenia[Ref]

Hepatic

Uncommon (0.1% to 1%): Increases in hepatic enzymes (usually reversible)

Frequency not reported: Blood creatine phosphokinase increased

-Amlodipine component: Very rare (less than 0.01%): Hepatitis; Frequency not reported: Hepatic enzyme elevations, jaundice

-Hydrochlorothiazide component: Rare (less than 0.1%): Intrahepatic cholestasis, jaundice.

-Valsartan component: Very rare (less than 0.01%): Hepatitis; Frequency not reported: Elevated liver enzymes[Ref]

Hypersensitivity

Rare (less than 0.1%): Nausea, diarrhea, rash, acute pulmonary edema, interstitial nephritis or cystitis, anaphylaxis, erythema multiforme, vasculitis, serum sickness

-Hydrochlorothiazide component: Frequency not reported: Photosensitivity, urticaria, necrotizing angiitis (vasculitis and cutaneous vasculitis), fever, respiratory distress including pneumonitis and pulmonary edema, anaphylactic reactions[Ref]

Immunologic

Common (1% to 10%): nasopharyngitis (2.1%), Respiratory tract infection, bronchitis, influenza, viral infection, tooth abscess, viral gastritis, rhinitis

Rare (0.01% to 0.1%): Allergic vasculitis, hemolytic anemia

-Amlodipine component: Uncommon (0.1% to 1%): Angioedema, erythema multiforme

-Hydrochlorothiazide component: Very rare (less than 0.01%): Necrotizing vasculitis

-Valsartan component: Frequency not reported: Angioedema[Ref]

Metabolic

Common (1% to 10%): Edema

Rare (0.01% to 0.1%): Hypokalemia, hyperkalemia, metabolic alkalosis, hyponatremia, hypomagnesemia, hypercalcemia, hyperglycemia, elevated serum uric acid levels, elevated serum cholesterol

Frequency not reported: Weight loss, blood uric acid increased, blood creatine phosphokinase increased, hypokalemia, diabetes mellitus, hyperlipidemia, hyponatremia, night sweats

-Amlodipine component: Frequency not reported: Hot flushes, malaise, rigors, hyperglycemia, thirst, weight gain

-Hydrochlorothiazide component: Frequency not reported: Glycosuria, hyperuricemia

-Valsartan component: Common (1% to 10%): Hyperkalemia[Ref]

Musculoskeletal

Common (1% to 10%): Back pain, muscle cramps

Frequency not reported: Myalgia, asthenia, noncardiac chest pain, pain in extremity, arthralgia, muscular weakness, musculoskeletal pain weakness, musculoskeletal stiffness, joint swelling, neck pain, osteoarthritis, tendonitis

-Amlodipine component: Frequency not reported: Arthrosis, muscle cramps, muscle cramps, muscle weakness, ataxia, hypertonia

-Hydrochlorothiazide component: Frequency not reported: Myalgia, chills

-Valsartan component: Rare (less than 0.1%): Rhabdomyolysis; Frequency not reported: Back pain, muscle cramps[Ref]

Nervous system

Common (1% to 10%): Headache, fatigue, dizziness, chills, malaise

Rare (less than 0.1%): Vertigo, tinnitus

Frequency not reported: Vertigo, paresthesia, somnolence, syncope, carpal tunnel syndrome, disturbance in attention, dysgeusia, head discomfort, lethargy, sinus headache, tremor

-Amlodipine component: Frequency not reported: Peripheral neuropathy, tremor, increased sweating

-Hydrochlorothiazide component; Frequency not reported: Restlessness

-Valsartan component: Frequency not reported: Headache, orthostatic effects, (including dizziness), vertigo[Ref]

Ocular

Rare (less than 0.1%): Abnormal vision, blurred vision

-Amlodipine component: Rare (less than 0.1%): Xerophthalmia; Frequency not reported: Abnormal vision, conjunctivitis, diplopia, eye pain

-Hydrochlorothiazide component: Frequency not reported: Transient blurred vision, xanthopsia, idiosyncratic reactions resulting in acute transient myopia and acute angle-closure glaucoma[Ref]

Psychiatric

Rare (less than 0.1%): Anxiety, depression, decreased libido, insomnia, paresthesias, somnolence

-Amlodipine component: Uncommon (0.1% to 1%): Insomnia, nervousness, depression, abnormal dreams, depersonalization, parosmia, mood changes, apathy, agitation, amnesia;

-Hydrochlorothiazide component: Rare (less than 0.1%): Sleep disturbances, depression

-Valsartan component: Frequency not reported: Insomnia[Ref]

Renal

Rare (less than 0.1%): Renal insufficiency, azotemia

-Amlodipine component: Rare (less than 0.1%): Interstitial nephritis

-Hydrochlorothiazide component: Rare (less than 0.1%): Interstitial nephritis; Frequency not reported: Increase in serum creatinine and BUN (which may be due to hydrochlorothiazide-induced intravascular volume depletion)

-Valsartan component: Frequency not reported: Impaired renal function, serum creatinine increased, blood urea nitrogen increased, potassium increased[Ref]

Respiratory

Uncommon (0.1% to 1%): Dyspnea, acute pulmonary edema

-Amlodipine component: Frequency not reported: Pulmonary edema, nasal congestion, cough, pharyngolaryngeal pain

Hydrochlorothiazide component: Rare (less than 0.1%): Acute noncardiogenic pulmonary edema

-Valsartan component: Common (1% to 10%): Cough; Frequency not reported: Sinusitis, pharyngitis[Ref]

Genitourinary

Rare (less than 0.1%): Dysuria, urinary tract infection, erectile dysfunction, pollakiuria.

-Amlodipine component: Frequency not reported: Micturition frequency, micturition disorder, nocturia, gynecomastia

-Hydrochlorothiazide component: Common (1% to 10%): Dysuria

-Valsartan component: Rare (0.01% to 0.1%): impotence[Ref]

Endocrine

Frequency not reported: Glucose intolerance, altered lipid profile

Other

Frequency not reported: Ear and labyrinth disorders, tinnitus[Ref]

References

1. Product Information. Norvasc (amlodipine). Pfizer U.S. Pharmaceuticals. 2002;PROD.

2. Product Information. HydroDIURIL (hydrochlorothiazide). Merck & Co., Inc. 2002;PROD.

3. Product Information. Diovan (valsartan). Novartis Pharmaceuticals. 2001;PROD.

4. Cerner Multum, Inc. Australian Product Information.

5. Product Information. Exforge HCT (amlodipine / hydrochlorothiazide / valsartan). Novartis Pharmaceuticals. 2009.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.